Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Chronic Uveitis
NCT00314665Phase 4Terminated
- Sponsor
- University of Cincinnati
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thalidomide in uveitis, sponsored by University of Cincinnati. Primary endpoints: Need for corticosteroids to control eyes and Global assessment of ocular status. Started Jan 2004; status: terminated.
02
Drugs
thalidomide
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT00314665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314665.